Successful management of congenital dyserythropoietic anemia type I with interferon alpha in a child.

Abstract

Congenital dyserythropoietic anemia type I (CDA I) is a rare inherited hematological disorder characterized by macrocytic anemia and ineffective erythropoiesis with pathognomonic morphological features that include internuclear chromatin bridges, spongy heterochromatin, and invagination of the cytoplasm into the nuclear area in erythroid precursors. Treatment of anemia with the usual hematinics is without effect and 15% of patients need chronic transfusions. Successful treatment of CDA I with interferon-alpha was noted. The authors report a patient with CDA I who had required transfusions every 2-3 months since the neonatal period and responded to recombinant interferon-alpha therapy with the findings of electron microscopic investigations.

• Authors: Neşe Yarali, Tunç Fişgin, Feride Duru, Pergin Atilla, Sevda F Müftüoğlu, S F Kaymaz
• Journal: Pediatric hematology and oncology (Pediatr Hematol Oncol) Vol. 22 Issue 4 Pg. 265-70 (Jun 2005) ISSN: 0888-0018 [Print] England
• PMID: 16020112 (Publication Type: Case Reports, Journal Article)

Chemical References

• Interferon-alpha

Topics

• Anemia, Dyserythropoietic, Congenital (blood, drug therapy)
• Disease Management
• Erythrocytes (drug effects, pathology, ultrastructure)
• Female
• Humans
• Infant
• Interferon-alpha (therapeutic use)
• Male
• Microscopy, Electron
• Treatment Outcome